Safety of corticosteroid therapy in sarcoidosis treatment
Introduction: Sarcoidosis is a multisystemic granulomatous disease of unknown origin and unpredictable cause, characterized by a dysregulated immune response. If histopathological hallmark is represented by the presence of non-caseating granulomas, clinical manifestations are variable and symptoms a...
Saved in:
| Main Authors: | Alessandro Di Marco Berardino, Federico Mei, Lina Zuccatosta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-12-01
|
| Series: | Frontiers in Drug Safety and Regulation |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fdsfr.2023.1319931/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE PROBLEM OF RECURRENCE OF SARCOIDOSIS IN THE PRACTICE OF OUTPATIENT PHYSICIAN
by: A. Yu. Chernikov, et al.
Published: (2016-10-01) -
State-of-the-Art Treatments for Sarcoidosis
by: Ilias C. Papanikolaou, et al.
Published: (2022-03-01) -
Experience of sarcoidosis and factors predicting relapse at a tertiary care institute in North India
by: Alok Nath, et al.
Published: (2019-01-01) -
Sarcoidosis as a disease associated with metabolic syndrome
by: I. D. Bespalova, et al.
Published: (2023-10-01) -
Sarcoidosis-Associated Pulmonary Hypertension
by: Yoshitaka Morimatsu, et al.
Published: (2025-02-01)